Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02827669 · ClinicalTrials.gov registry record · NA
One Drop Experts Program for Type 2 Diabetes Self-Management: Impact on A1c
A NA study, sponsored by Evidation Health.
- Completed
- Registry status
- NA
- Development phase
- 297
- Enrollment target
NCT02827669: Completed NA study, sponsored by Evidation Health.
NCT02827669 is a NA study that has completed, run by Evidation Health. The registered enrollment target is 297 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02827669, a NA study, has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 297 participants
- Enrollment target
Study Summary
The One Drop Experts Program for Type 2 Diabetes Self-Management Impact on A1c trial is a 12-week long, prospective, intent-to-treat study that aims to evaluate the impact of the One Drop app and Experts program on HbA1c levels for individuals with uncontrolled Type 2 diabetes. A secondary objective will be to evaluate participants who utilize an Apple Watch in combination with the One Drop app and Experts program, and assess whether this group is more engaged or experiences a different impact as compared to participants who utilized the One Drop app and Experts program only.
Interventions
- BEHAVIORAL One Drop Experts Program
- BEHAVIORAL One Drop Experts Program + Apple Watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-02 |
| Phase | NA |
What the finished NCT02827669 record still lists
NCT02827669 is an interventional study that assigns participants to a tested intervention. The registered 297 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which One Drop Experts Program is the first listed.
NCT02827669 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02827669 about?
NCT02827669 is a clinical study titled "One Drop Experts Program for Type 2 Diabetes Self-Management: Impact on A1c". The One Drop Experts Program for Type 2 Diabetes Self-Management Impact on A1c trial is a 12-week long, prospective, intent-to-treat study that aims to evaluate the impact of the One Drop app and Experts program on HbA1c levels for individuals with uncontrolled Type 2 diabetes. A secondary objective...
What is the current status of trial NCT02827669?
This trial is currently completed. It is a NA study. The enrollment target is 297 participants. The study started on 2016-06. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02827669?
The interventions under investigation include: One Drop Experts Program (BEHAVIORAL), One Drop Experts Program + Apple Watch (BEHAVIORAL).
Who is sponsoring clinical trial NCT02827669?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02827669's enrollment target sits among peer trials
297 372nd of 2000 higher than 1,628 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
- NCT06375811 · 297 participants · Phase 3
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
- NCT07222215 · 297 participants · Phase 2
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia